文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

与妊娠期mRNA新冠疫苗接种相关的个体和家庭因素:一项大规模注册登记 linkage 研究

Individual and familial factors associated with mRNA COVID-19 vaccine uptake in pregnancy: A large-scale registry-based linkage study.
PubMed 文献 · Vaccine · 2024-07-30

基于挪威全国注册登记 linkage 数据,纳入2021-2022年101,659例孕周≥12周的分娩,分析妊娠期至少接种一剂mRNA新冠疫苗的 uptake 及其个体与家庭因素。妊娠期任意剂量接种率从2021年8月中旬前的<1%升至2021年余下时间的38.8%和2022年的48.9%;重症新冠高风险或哮喘孕妇中仅28.8%和33.9%至少接种一剂。父亲接种疫苗与孕妇接种 strongly associated(调整RR 7.2,95%CI 6.8-7.5)。

要点

  • 妊娠期任意剂量接种率:2021年8月中旬前<1%,2021年余下时间38.8%,2022年48.9%。
  • 重症新冠高风险孕妇仅28.8%、哮喘孕妇仅33.9%至少接种一剂。
  • 父亲接种与孕妇接种调整RR 7.2(95%CI 6.8-7.5)。

核心结论

  • 尽管妊娠期新冠疫苗接种率上升,重症高风险个体的接种率仍低。
  • 父亲接种、孕前感染、移民身份和母亲公民身份与产前疫苗接种 strongly associated。
  • 该知识可帮助定制未来的疫苗接种活动。

研究设计与样本

  • 基于挪威全国注册登记 linkage 数据,纳入2021-2022年101,659例孕周≥12周的分娩。
  • 结局为妊娠期至少接种一剂mRNA新冠疫苗,采用窄定义(首次 ever 剂量)和宽定义(任意剂量)。
  • 拟合单变量和多变量 modified Poisson 回归模型,按居住县聚类并调整日历时间,估计风险比(RR)及95%置信区间(CI)。

主要发现

  • 妊娠期任意新冠疫苗剂量接种率从2021年8月中旬前的<1%升至2021年余下时间的38.8%和2022年的48.9%。
  • 重症新冠高风险孕妇中仅28.8%至少接种一剂新冠疫苗,哮喘孕妇中仅33.9%。
  • 父亲新冠疫苗接种与孕妇接种 strongly associated(调整RR 7.2,95%CI 6.8-7.5)。
  • 母亲孕前SARS-CoV-2感染(调整RR 0.31,95%CI 0.26-0.37)、家庭和个体移民身份与妊娠期接种可能性 considerable 降低相关。
  • 流产史或妊娠合并先天畸形史与疫苗接种无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The association between maternal COVID-19 vaccination in pregnancy and factors such as high risk for severe COVID-19, pre-existing asthma, prior adverse reproductive history, or paternal COVID-19 vaccination during pregnancy, remains unclear. The aim of this study is two-fold: (i) to describe uptake of COVID-19 vaccine during pregnancy by maternal risk for severe COVID-19 and asthma, and (ii) to comprehensively examine individual and familial factors associated with vaccine uptake during pregnancy in Norway. Based on nation-wide registry-linkage data in Norway, we included 101,659 deliveries with gestational length ≥12 weeks, in 2021-2022. Our outcome measure was uptake of at least one dose of mRNA COVID-19 vaccine during pregnancy, using a narrow (first ever dose) and broad (any dose) definition. We fit univariate and multivariate modified Poisson regression models, clustered by county of residency and adjusted for calendar time, to estimate risk ratios (RR) with 95 % Confidence Intervals (CIs). Gestational uptake of any COVID-19 vaccine dose increased from <1 % before mid Aug-2021, to 38.8 % in the rest of 2021, and 48.9 % in 2022. Only 28.8 % and 33.9 % pregnant individuals with high risk for severe COVID-19 or asthma, respectively, received at least one COVID-19 vaccine dose. Paternal COVID-19 vaccination was strongly associated with greater vaccine uptake by pregnant individuals (adjusted RR: 7.2, 95 % CI: 6.8-7.5). Maternal SARS-CoV-2 infection pre-pregnancy (adjusted RR: 0.31, 95 % CI: 0.26, 0.37), familial and individual migrant status were associated with a considerable decreased likelihood of vaccine uptake in pregnancy. History of miscarriage or pregnancy with congenital anomaly were not associated with vaccine uptake. Despite rising COVID-19 vaccine rates in pregnancy, uptake remained low for high-risk individuals. Paternal vaccination, pre-pregnancy infection, migration status, and maternal citizenship were strongly associated with prenatal vaccine uptake. This knowledge can inform tailoring of future vaccination campaigns.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Elyass J, Desalegn A, Trinh NTH, et al. Individual and familial factors associated with mRNA COVID-19 vaccine uptake in pregnancy: A large-scale registry-based linkage study. Vaccine. 2024. PMID: 39079814. doi:10.1016/j.vaccine.2024.126171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。